The Florida Pediatric NCORP: NCI Community Oncology Research Program.

Project Summary The Florida Pediatric NCORP is a consortium of five Florida pediatric hem/onc hospitals. The NCORP geographically covers a large portion of Florida and provides pediatric oncology care to the largest population centers in Florida, the third largest state in the country. The hospitals are located in Ft. Myers, Hollywood, Orlando, and two sites inTampa, as well as the Central Office. Over a 34 year period the Florida Pediatric CCOP, and since 2014, the Florida Pediatric NCORP has been one of the single largest contributor of patients to COG treatment, cancer control, and more recently, cancer care delivery studies. The CCOP, and now the NCORP, has consistently had outstanding compliance scores and contributes to the administration and science of COG through its members who chair or co-chair research base protocols. The goal of the Florida Pediatric NCORP is to continue the ongoing effort to make available the latest advances in cancer care to patients in Florida through participation in clinical trials and to register the majority of their eligible patients on COG protocols, thereby providing quality care in patients’ home communities. The Florida Pediatric NCORP provides a unique opportunity to study a geographically-defined population to investigate risk factors, patterns of care, and population-based interventions. The Florida Pediatric NCORP also maintains a Patient Log which affords the opportunity to ensure the majority of eligible patients are registered on appropriate COG protocols. Over the last grant cycle, the five Florida Pediatric NCORP participating sites have averaged over 420 patient registration on COG treament, cancer control, and cancer care delivery protocols, as well as 500 biospeciem and special entries. The Florida Pediatric NCORP anticipates increased patient registrations as more COG treatment, cancer control, and cancer care delivery protocols become available. COG quality-control procedures will apply uniformly to the Florida Pediatric NCORP, ensuring compliance with protocols and external review of pathology, radiotherapy, surgery, and chemotherapy. The recent affilation with the Rochester Research Base will provide an opportunity to particpate in available AYA trials.